# Olopatadine Hydrochloride Ophthalmic Solution

NDC: 0536-1308
Generic name: Olopatadine Hydrochloride Ophthalmic
Labeler / Manufacturer: Rugby Laboratories
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20210105
Marketing ended: 20260630
FDA application: ANDA209619

## Active ingredients

- OLOPATADINE HYDROCHLORIDE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0536-1308"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0536-1308
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7bcba63-bfaf-240b-199e-2e42a91c19c9